Background: In Gram-negative bacteria, passing through the double membrane barrier to reach the inhibitory concentration inside the bacterium is a pivotal step for antibiotic activity. Spectrofluorimetry has been developed to follow fluoroquinolone accumulation inside bacteria using intrinsic bacterial fluorescence as an internal standard. However, adaptation for non-fluorescent antibiotics is needed; quantitative methods based on MS offer the possibility of expanding the detection range obtained by spectrofluorimetry.
Introduction
A major challenge in bacterial chemotherapy is to determine and carefully use the in situ parameters that modulate the activity of drugs in order to improve antibacterial efficacy. 1, 2 This is particularly important with the continuing emergence and spread of MDR bacteria that contribute to therapeutic failure. [3] [4] [5] [6] Several articles illustrate the intensity and relevance of this concern and it is an absolute requirement to understand membrane permeation and intracellular concentration of antibiotics in clinical isolates; crossing the double membrane barrier to reach a threshold concentration is a pivotal step of antibacterial action. [7] [8] [9] [10] [11] [12] [13] [14] [15] This key point has not been strongly addressed until now or only in a few specific cases with characterized bacterial strains. 10, 13, 16, 17 As recently reported, 10, 18, 19 there is a large collection of methods available to measure efflux activity but their sensitivity and validity must be clearly demonstrated under different conditions. Thus, the lack of appropriate assays containing well-defined internal controls that allow standardization of signals obtained with various strains under various conditions is a serious bottleneck for medicinal chemistry efforts aiming to optimize antibiotic intracellular accumulation. MS appears to be a promising technique to determine the intracellular accumulation of label-free compounds. [20] [21] [22] [23] [24] V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Ultimately, this approach might help to characterize the membrane permeation of any potential drugs, quantify antibiotic accumulation kinetics with appropriate internal controls and meet the throughput requirements of optimization programmes based on the structure-activity relationship. In the case of fluorescent drugs, intracellular accumulation can be monitored using a synchrotron light source and use the intrinsic fluorescence of bacterial amino acids as a powerful internal standard to correct for biological variations associated with bacterial samples. 25 For example, the fluoroquinolone antibiotic fleroxacin exhibits sufficient changes in fluorescence intensity to monitor its accumulation in single bacterial cells. 25, 26 Recent results allowed us to validate this method with an MDR clinical strain of Enterobacter aerogenes and an efflux pump-deficient (DtolC) derivative of this strain, demonstrating the importance of using a robust internal control. 27 The Innovative Medicine Initiative-funded consortium, Translocation 28 (www.imi.europa.eu/projects-results/project-fact sheets/translocation), has defined as its main objective the study of antibiotic translocation across bacterial membranes. 17 The consortium uses new approaches, and more traditional ones, to improve our understanding of drug transport and to support future strategies in order to face the antibiotic resistance crisis. In this context, it is important to define common standards and/or protocols to validate the new methods and for future correlation with antibacterial activities. 10, 29 This is the main objective of this study, which proposes a joint protocol for spectrofluorimetry and MS analyses associated with biological/biochemical characterizations of bacterial samples. From this work, a new perspective emerges on how to measure the kinetics of antibiotic uptake inside bacterial cells and correlate them with the antibiotic mode of action in order to: (i) understand and combat the emergence and spread of resistant strains; and (ii) extend the activity of antibiotics; or (iii) upgrade the design of new molecules. In addition, this study contributes to the recently proposed concepts, 'Resident Time Concentration Close to Target' (RTC2T) and 'Structure Intracellular Concentration Activity Relationship' (SICAR). 10 
Materials and methods

Bacteria and media
Escherichia coli strains used in this study are listed in Figure 1 . These isogenic strains have been previously described regarding their antibiotic susceptibility. 30 
Immunodetection
Exponential-phase bacteria in liquid Mueller-Hinton II (MH2) medium were centrifuged and the pellet was solubilized in loading buffer. 31 Total cell protein (OD 600 " 0.02 corresponding to equal protein per well) was loaded onto an SDS-polyacrylamide gel [10% polyacrylamide (w/v), 0.1% SDS (w/ v)]. Proteins were electrotransferred onto nitrocellulose membranes in transfer buffer. An initial saturating step was performed overnight at 4 C with Tris-buffered saline (TBS: 50 mM Tris-HCl, pH 8.0, 150 mM NaCl) containing skimmed milk powder (10%). The nitrocellulose sheets were then incubated in TBS with skimmed milk powder and Triton X-100 (0.2%) for 2 h at room temperature in the presence of polyclonal antibodies (1:5000, 1:2000 and 1:10 000 dilution for anti-AcrA, anti-AcrB and anti-OmpF, respectively) directed against denatured AcrA, AcrB, OmpC and OmpF respectively. 31 The detection of antigen-antibody complexes was performed with horseradish peroxidase secondary antibody-conjugated Immune-Star goat anti-rabbit IgG antibodies (BioRad) and imaging was performed using a ChemiDoc XRS! (BioRad).
Drug susceptibility assays
Ciprofloxacin and fleroxacin were assayed to study the antibiotic susceptibility of E. coli strains. MICs were determined by the microdilution method (CLSI) in MH2 medium by using the 2-fold standard microbroth dilution method (microplates and automatic analysis using a Tecan V R reader) (CLSI, http://clsi.org/). MIC values were read after 18 h of incubation at 37 C. Experiments were carried out in triplicate and the resulting medians are presented.
Accumulation protocol
Bacteria grown at 37 C in LB broth in exponential-phase growth (OD 600 " 0.6) were concentrated 10-fold. The bacterial suspension was centrifuged at 6000 g for 15 min at 20 C and pellets were resuspended in 1/10 of the initial volume in a sodium phosphate buffer (50 mM) at pH 7 supplemented with MgCl 2 (5 mM) (NaPi/MgCl 2 buffer) to obtain a density of 6%10 9 cfu/mL. In 96-well deep-well plates, 1.44 mL of the bacterial suspension was incubated for 2 or 10 min at 37 C (final volume 1.8 mL per well) with different concentrations of fleroxacin and ciprofloxacin (0-5 mg/L), in the absence or presence of the efflux blocker CCCP (10 lM) for the efflux pump overproducer strain AG102. CCCP collapses the energy-driven force needed by the efflux pump to expel antibiotics in the resistant strain. 32 Bacterial suspensions incubated without antibiotics, with or without CCCP, were used as controls. Suspensions (800 lL) were then loaded on 1 M sucrose cushions (1.1 mL) in two deep-well plates (one for the spectrofluorimetry analysis and the other for the MS analysis) and centrifuged at 2700 g for 20 min at 4 C to eliminate extracellular-adsorbed compounds and collect washed bacteria. 29 The same incubation mixtures were used to perform spectrofluorimetry and MS analyses, in three replicates each. This accumulation assay was repeated three times.
To check that the bacterial cells were alive during the experiments, the number of cfu was determined by sampling the bacterial suspension at 2 and 10 min during antibiotic incubation. The cfu numbers were determined and no change in cell viability was observed during this period, which corresponds to the accumulation assay (data not shown). It must be noted that the ratio 'bacterial cells/antibiotic concentration' was different in the MIC assay and the accumulation assay (about 10-20% higher in accumulation conditions compared with MIC assays). Furthermore, the accumulation assay was carried out using starvation conditions for a limited incubation time (2-10 min) as previously determined. 27 
Spectrofluorimetry assay
To follow the compound uptake by the bacterial population, the fluorimetric assay previously described was used. 25 Pellets corresponding to 800 lL of bacterial suspensions were lysed with 500 lL of 0.1 M glycine-HCl pH 3 buffer overnight at room temperature. The lysis efficacy was checked by cfu determination as previously mentioned. 29 After centrifugation in deep wells for 20 min at 2700 g at 4 C, 100 lL of lysate was analysed by spectrofluorimetry at k ex 290 nm and k em around 450 nm for fleroxacin and k ex 275 nm and k em around 450 nm for ciprofloxacin. To quantify the fluoroquinolone fluorescence intensity in bacterial lysates, spectra were normalized using the tryptophan peak at 356 nm and subtracted from control sample spectra. 27 Fluoroquinolone concentrations in bacterial lysates were calculated according to a calibration curve (see 'Standard curves' section). 29 
MS determination Sample preparation for MS analysis
Pelleted bacteria were thawed for 10 min at 37 C and resuspended in 200 lL of 0.1 M glycine-HCl pH 3 buffer. Samples were sonicated for 5 min (sonic batch) and incubated at 37 C for 2 h under gentle agitation. The lysis efficacy was checked by cfu determination (data not shown). After a first centrifugation at 6100 g (10 min, room temperature), 150 lL of the Combined methods for studying antibiotic transport JAC supernatant was recovered and centrifuged a second time under the same conditions. Forty micolitres of these final supernatants were then put in a 96-well plate for MS analysis.
MS analysis
Quantitative analysis was performed on a Waters ACQUITY UPLC HSS T3 column (1.8 lm, 50%2.1 mm) at room temperature with the flow rate of the mobile phase set at 0.5 mL/min. The mobile phase consisted of (A) 0.1% formic acid in water and (B) 0.1% formic acid in 95% acetonitrile, 5% water. A linear gradient elution programme was applied as follows: 0-1 min: 0%-100% B; 1-1.3 min: 100% B; 1.3-1.4 min: 100%-0% B; 1.4-2 min: 0% B. The sample injection volume was 5 lL.
All the MS experiments were performed using a TSQ Quantiva mass spectrometer (Thermo Scientific, San Jose, CA, USA) interfaced with an UltiMate 3000 XRS UHPLC system (Thermo Scientific, San Jose, CA, USA). Data were processed using TraceFinder version 3.3 (Thermo Scientific, San Jose, CA, USA).
MS detection was performed in positive ion mode and each drug was quantified using one selected reaction monitoring transition (dwell time 50 ms): m/z 332.141 to .287.986 for ciprofloxacin and 370.181 to .326.111 for fleroxacin. Details regarding collision energy and RF lens values are presented in Table 1 .
Standard curves MS
Solutions of each compound for calibration were freshly prepared in bacterial lysate. From a first concentration of 5 mg/L, 4-fold serial dilutions were done in bacterial lysate to a final concentration of 0.076 ng/mL, leading to nine solutions used for MS calibration curves ( Figure S1 available as Supplementary data at JAC Online).
Spectrofluorimetry
Various known concentrations of fleroxacin and ciprofloxacin were mixed with bacterial lysates at OD " 4.8 and samples were measured by spectrofluorimetry (n " 3) at k ex 290 or 275 nm, respectively, and k em around 450 nm. The trend lines and the slopes of the fleroxacin and ciprofloxacin standard curves were determined in the various studied bacterial lysates ( Figure S2 ). The corrected fluorescence value of each spectrofluorimetry sample (corrected with the fluorescence signal from bacteria as previously described) 27 was divided by the slope of the trend line to obtain the fleroxacin and ciprofloxacin concentrations.
Results and discussion
Fluoroquinolone susceptibility and AcrAB expression
The activities of fleroxacin and ciprofloxacin were assayed on E. coli AG100, AG100A (a derivative strain devoid of the AcrAB efflux pump) and AG102 (a strain that overproduces AcrAB) (Figure 1a) . The same strains were used for both detection methods. In general, AG100A was more susceptible to the drugs than the WT, while AG102 was more resistant. Immunoblots confirmed the absence of AcrAB in AG100A and a more intense signal in 
MS versus spectrofluorimetry to evaluate fluoroquinolone accumulation
In order to compare the two approaches for determining the antibiotic accumulation in various efflux backgrounds, an experimental protocol was designed (see Figure S3) . In this protocol, we generated duplicate samples for each experimental point (e.g. strain, time, drug concentration). Each sample was analysed in triplicate (corresponding to three independent wells) using spectrofluorimetry or MS (blind assay).
Ciprofloxacin accumulation
The analysis was performed on measurements of ciprofloxacin concentrations accumulated in all studied strains (AG100, AG100A, AG102 and AG102 incubated with CCCP) at 2 and 10 min of incubation (Figure 2 ). The consistency between spectrofluorimetry and MS was quantified by Bland-Altman calculations (Figure 2) . The difference is centred around zero with neither absolute systematic error nor strong dependency on the magnitude of measurements. The observed bias is relatively low (297+5477 molecules/cell) and not significant, and biases are similar between incubations of 2 and 10 min (data not shown). Under the conditions used, the two methods gave equivalent results.
Fleroxacin accumulation
The results are presented in Figure S4 . As observed with ciprofloxacin, the Bland-Altman plot demonstrated the consistency of the measurements obtained with spectrofluorimetry and MS (bias of 263+4008 molecules/cell). The difference is centred around zero and no proportional error is present in the comparison between the two methods. It must be noted that in the case of fluorimetry alone, as reported previously, the internal signal corresponding to intrinsic bacterial fluorescence (tryptophan fluorescence) was systematically used to correct the data for the variation of cellular masses presented in the various samples. 27, 29 The fact that spectrofluorimetry measurements are corrected with the bacterial internal standard, unlike MS data, may explain the ranges of agreement obtained on the Bland-Altman plots. Another specific point concerns the detection limit of spectrofluorimetry: it cannot be used to detect accumulations performed with concentrations ,500 ng/mL under the conditions used. In contrast, MS gives access to a wider range of low concentrations (down to 25 ng/mL) in our conditions.
Concentration effect, influx and efflux activity
The measurement of the accumulation of compounds inside the E. coli AG100A strain (devoid of the AcrAB pump) can be used to determine the respective efficiency of ciprofloxacin and fleroxacin uptake. The results presented in Figure 3 indicate that ciprofloxacin is about 2-fold more efficiently accumulated compared with fleroxacin in the absence of AcrAB efflux. A quite similar value has been calculated using a spectrofluorimetry assay and previously proposed for the concept SICAR IN (IN " influx) . 32 In this study, the MS assay also shows a difference in uptake for ciprofloxacin and fleroxacin (Kruskal-Wallis test, P , 0.01, n " 27).
To evaluate the impacts of external concentration effect and/or of efflux level on the rate of intracellular accumulation, a large range of ciprofloxacin concentrations were incubated with the parental strain, the AcrAB# derivative and the AcrAB overproducer isogenic strains. The data obtained with MS analyses are presented in Figure 4 . A strong difference was observed between the accumulations in the different AcrAB strains: the maximum accumulation, whatever the concentration used, was obtained with AG100A or with AG102 in the presence of CCCP; in contrast, the minimum Mass spectrometryspectrofluorimetry measurements
Mean of mass spectrometry and spectrofluorimetry measurements Combined methods for studying antibiotic transport JAC was obtained with AG102 (P , 0.001). Moreover, the overproduction of AcrAB in AG102 has a noticeable effect on ciprofloxacin accumulation at high concentrations (3.75 and 5 lg/mL) compared with the basal pump expression obtained in AG100 (P , 0.05). Figure 5 ). These results suggest that a saturation of the efflux ability to expel the internalized molecules can be reached in the E. coli strain that overproduced AcrAB when a high concentration of ciprofloxacin is used.
These data explain the key contribution of efflux pumps in fluoroquinolone resistance in clinical strains in which the uptake of antibiotic can be impaired by alteration of the membrane permeability as previously hypothesized. 10 
Conclusions
A variety of methods have been previously reported to monitor the intracellular accumulation of antibiotics in enterobacterial cells that feature membrane-associated mechanisms of resistance affecting many or all antibiotic classes, including reduction of outer membrane permeability or increased levels of efflux pumps. 10, 18 Until now, and despite recent methodology efforts, no comparative assays have been carried out in order to have an independent validation of the proposed protocols or at least to check their consistency and robustness.
In this study, our aim was to determine the internal concentration of fluoroquinolones, ciprofloxacin and fleroxacin, and to measure the effect of antibiotic concentrations on bacteria expressing various levels of AcrB pump, using fluorimetric and mass spectrometric (LC-MS/MS) methods.
For the first time, a robust consistency was described between these two approaches, spectrofluorimetry and MS, whatever the efflux activity, the molecule or the concentration of antibiotic used in the assays. Moreover, by combining the spectrofluorimetry measurement, which contains a reliable internal standard, 29 with LC-MS/MS determination, which allows low concentrations of molecules to be studied, these two methods can be viewed as complementary. Our study is especially important in view of recent papers reporting the accumulation of antibacterial molecules using MS assay when this assay lacks a robust internal control for normalization. 23 The development of LC-MS/MS assays in microplates allows determination of the relationship between a large range of antibiotic concentrations and the amount of intrabacterial accumulation in different efflux backgrounds with and without the presence of an efflux inhibitor (CCCP). Importantly, the data demonstrate that ciprofloxacin penetrates and accumulates more than fleroxacin in an AcrAB# strain. The measurement of uptake in the absence of efflux activity, defined by SICAR IN as previously proposed, 32 is thus confirmed. With increasing external concentrations of compound, the effect of efflux on internal accumulation was altered and the accumulation ratio obtained between AcrAB# and AcrAB overproducer strains was significantly decreased, showing that efflux can be saturated. This effect must be taken into consideration when assessing the impact of efflux on new antibacterial agents.
In addition, the fact that efflux pumps can indeed be saturated supports the strategy previously proposed by several authors to generate substrate competition at the binding sites of efflux pumps by using molecular lures or adjuvants to restore the intracellular antibiotic concentrations. 31, [33] [34] [35] [36] Intrinsic bacterial fluorescence has been previously used to standardize/normalize the data in the quantification assays for fluorescent drugs. 25 In this study, the good correlation between mass spectrometric determination and fluorimetric analyses demonstrated the advantage of this internal measure for monitoring the efficacy of the lysis protocol and correcting the crude signals for protocol validation. ANOVA and Tukey's post-hoc tests were performed to determine differences between the various strains (n " 9). ***, P , 0.001; **, P , 0.01, *, P , 0.05. Data normality was checked by the Shapiro-Wilk test and homogeneity of variances was checked by the Fligner-Killeen test. Combined methods for studying antibiotic transport
JAC
In the future, it will be necessary to develop additional assays using methods similar to the one described here to measure, in whole bacteria, the apparent affinities of various antibiotics for the different bacterial transporters involved in the influx step (e.g. porins) or involved in the efflux step (e.g. other AcrAB family members).
To conclude, with this method the previously proposed concept of SICAR 10, 19 has now been applied to a large concentration range. In structure-activity relationship studies for biologically active molecules, SICAR will correlate the chemical structure to the efficacy of translocation through the bacterial membrane and the resulting intracellular accumulation, while taking into account recently proposed key parameters, such as globularity and charge, as reported by Richter et al. 23 Thus, the role of chemical side chains involved in the membrane permeation (IN) or in the efflux transport (OUT) can be dissected and allow the design of drugs that better fit the translocation constraints present in resistant clinical isolates.
